How Indian Pharmaceutical Exports Are Regulated: A Primer for Buyers
India's pharmaceutical export framework involves multiple regulatory bodies, each with a distinct role. For international buyers, understanding who does what helps you navigate documentation requirements, track down information independently, and have more informed conversations with your Indian supplier.
---
The Key Regulatory Bodies
1. CDSCO — Central Drugs Standard Control Organisation
Role: India's central drug regulatory authority, operating under the Ministry of Health and Family Welfare. CDSCO is the Indian equivalent of the US FDA or the EU's EMA. Relevant to exports: - Issues WHO-GMP certificates to manufacturers who pass inspection - Issues the Certificate of Pharmaceutical Product (CPP) / Free Sale Certificate (FSC) for export - Issues export NOC (Form 40/41) for certain drug categories - Regulates clinical trials and new drug approvals - Maintains the schedule of controlled substances Where to find them: cdsco.gov.in2. DGFT — Directorate General of Foreign Trade
Role: DGFT operates under the Ministry of Commerce and Industry and administers India's Foreign Trade Policy (FTP). It governs all imports and exports through licensing, the IEC system, and trade promotion schemes. Relevant to exports: - Issues and maintains the IEC (Import Export Code) - Administers export promotion schemes (RoDTEP — Remission of Duties and Taxes on Exported Products — relevant for pharma exporters claiming duty refunds) - Publishes the Foreign Trade Policy (updated periodically) which includes restrictions, prohibitions, and procedures for specific product categories - Manages SCOMET (Special Chemicals, Organisms, Materials, Equipment and Technologies) list — relevant for dual-use chemicals that sometimes overlap with pharma intermediates Where to find them: dgft.gov.in3. State Drug Controllers / State FDAs
Role: Each Indian state has its own drug regulatory authority (State Drug Controller / State FDA) responsible for licensing manufacturers and wholesale dealers within the state, and for conducting inspections. Relevant to exports: - Issue manufacturing licences for pharma products (Form 25/28 for manufacturers) - Issue wholesale dealer licences (Form 20B/21B) to traders - Available for licence verification (some state FDA portals allow public search)4. Pharmexcil — Pharmaceuticals Export Promotion Council of India
Role: Pharmexcil is a government-recognised Export Promotion Council under the Ministry of Commerce. Its role is to promote Indian pharmaceutical exports and provide services to member exporters. Relevant to exports: - Issues RCMC (Registration Cum Membership Certificate) — required for exporters to claim benefits under DGFT schemes - Provides market development support, trade fair participation, and regulatory assistance - Publishes export statistics and market intelligence - Liaison with foreign regulatory authorities for Indian pharma export matters Where to find them: pharmexcil.com5. Indian Customs (CBIC)
Role: The Central Board of Indirect Taxes and Customs (CBIC) oversees customs at ports of export. It processes Shipping Bills (India's export declaration), checks HS code classification, and clears export consignments.---
The Export Process in Brief
A typical pharmaceutical export from India flows through these regulatory touchpoints:
1. Manufacturer produces product under valid drug licence, with batch release QC 2. Trader/Exporter (Bharat Medex) purchases from manufacturer with proper documentation 3. Export NOC (Form 40/41) obtained from CDSCO if required for the specific product 4. Commercial documents prepared: invoice, packing list, CoA, CoO 5. Customs filing: Shipping Bill filed via ICEGATE (India's customs electronic platform), examined and cleared by Customs 6. FSC/CPP obtained from CDSCO or State FDA if required by the destination country for import registration 7. Freight forwarder arranges cargo booking (air or sea), Bill of Lading / Airway Bill issued 8. Bank documentation processed (LC negotiation or remittance confirmation) 9. DGFT scheme claims filed post-export (RoDTEP, etc.) if applicable
---
What This Means Practically for Buyers
As a buyer, you do not need to navigate Indian regulatory bodies directly — your supplier handles the Indian-side compliance. But knowing these bodies exist and their roles means you can:
- Independently verify your supplier's IEC (DGFT), drug licence (State FDA), and GMP certificate (CDSCO) - Request the right documents from your supplier — FSC from CDSCO, Form 41 if applicable, WHO CPP - Set realistic lead times — some regulatory documents (Form 40/41, FSC) have processing timelines; ask your supplier upfront
---
Contact Bharat Medex to discuss how we handle the regulatory and documentation process for your export orders.
0 comments